SPC/PIL of the products can differ from this general indication.
Abciximab is indicated in adults as an adjunct to heparin and acetylsalicylic acid for:
1. Percutaneous coronary intervention
The prevention of ischemic cardiac complications in patients undergoing percutaneous coronary intervention (balloon angioplasty, atherectomy and stent)
2. Unstable angina
The short-term (1-month) reduction of the risk of myocardial infarction, in patients with unstable angina, not responding to full conventional therapy who have been scheduled for percutaneous coronary intervention.
North AmericaCanada (0)